Page 14 - Valuating News Today

- Neumifil is a novel broad-spectrum anti-viral product that was shown to be well-tolerated with no safety signals at all doses tested - Pneumagen plans to conduct a Phase 2 Influenza challenge

WASHINGTON (dpa-AFX) - Biopharmaceutical company AbbVie Inc. (ABBV) announced on Wednesday positive topline results from U-ENDURE, its Phase 3 maintenance study evaluating upadacitinib in adult

Use of GeNeuro's temelimab as part of the first personalized medicine approach in severe post-COVID neuropsychiatric syndromes Biomarker-based study to detect the presence of the pathogenic

Revenue of $776 million in the First Quarter, up 7% Year-over-YearCore Revenue Grew 9% to $735 millionQuarterly Cash Flow From Operating Activities of $65 million SAN ANTONIO, May 10, 2022 (GLOBE NEWSWIRE)

President Joe Biden on Tuesday said that he is discussing the future of China tariffs imposed by the Trump administration cautioning that no decision has been made.

Pune (Maharashtra) [India], April 22 (ANI/NewsVoir): Achieving financial stability requires proper planning and a sound investment strategy

Rapid reversal of cytokine storm in septic patients Enhanced resolution of biomarkers for inflammation including leukocytosis compared to standard of care No treatment-related serious

Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival

LONDON (dpa-AFX) - Apollo Global Management, Inc. (APO) and its subsidiaries, on Wednesday, stated that Apollo has been unable to reach agreement with the board of Pearson (PSO, PSON.L) as to the

BUFORD, GA / ACCESSWIRE / March 29, 2022 / MasterBeat Corporation (OTC PINK:MSTO), a company specializing in hard, tangible asset acquisitions with an intense focus on real estate, collectible classic